how much is a vial of tirzepatide Injection | Starts at $249/mo dosing plans now available for BMI 20+. Tirzepatide – 60 mg Vial
Description
Top of mind for the fillfinish market on the CDMO/CMO side is Novo Holdings $16.5-billion acquisition of the CDMO, Catalent, a deal which closed last December (December 2024) and Novo Holdings subsequent sale of three fillfinish sites to Novo Nordisk for $11 billion to support Novo Nordisks blockbuster GLP-1 agonists, Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity
With TrimRx, the process moves through three stages
PMID: 20412332
Tirzepatide is supplied in pre-filled injection pens with various strengths
It's based on pharmacokinetic theory and community experience, not controlled studies
Nucleic acid synthesis is not affected
